Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GN.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GW.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.64NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AH.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.327NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.396NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.129NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AK.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.221.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.224NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.618NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.458NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.258.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AG.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.258.16NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
W.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.264.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.21 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.19NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AT.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.619.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.12.1 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AZ.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.260NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.456NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.16NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.4.16 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.70NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.42NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.428NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.374NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.63 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.377NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.258.15NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.298NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.30.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.76NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.258.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.31NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.385NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.384NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.32NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used